These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22039286)

  • 41. Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR.
    Pazhoomand R; Keyhani E; Banan M; Najmabadi H; Khodadadi F; Iraniparast A; Feiz F; Majidzadeh K; Bahman I; Moghadam FA; Sobhani AM; Muhammadnejad A; Abedini SS; Behjati F
    Asian Pac J Cancer Prev; 2013; 14(12):7621-8. PubMed ID: 24460343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
    Smith K; Houlbrook S; Greenall M; Carmichael J; Harris AL
    Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of HER2 gene status in breast cancer by chromogenic in situ hybridization: comparison with immunohistochemistry.
    Kounelis S; Kapranos N; Malamos N; Kouri-Bairaktari E
    Anticancer Res; 2005; 25(2A):939-46. PubMed ID: 15868931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL; Borelli KA; Hsu PH
    Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observer prediction of HER2 amplification in HercepTest 2+ breast cancers as a potential audit instrument.
    Going JJ
    Histopathology; 2011 Aug; 59(2):333-5. PubMed ID: 21884213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas.
    Taniyama K; Ishida K; Toda T; Motoshita J; Kuraoka K; Saito A; Tani Y; Uike T; Teramoto S; Koseki M
    Breast Cancer; 2008; 15(3):231-40. PubMed ID: 18264744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up.
    Jensen KC; Turbin DA; Leung S; Miller MA; Johnson K; Norris B; Hastie T; McKinney S; Nielsen TO; Huntsman DG; Gilks CB; West RB
    Breast Cancer Res Treat; 2008 Dec; 112(3):453-9. PubMed ID: 18193353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
    Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF
    J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma.
    Conlon S; Colgan A; Allen D; O'Grady A; Kay EW
    Histopathology; 2011 Jan; 58(2):319-21. PubMed ID: 21323957
    [No Abstract]   [Full Text] [Related]  

  • 50. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
    Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
    Anal Cell Pathol (Amst); 2010; 33(1):13-8. PubMed ID: 20966540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.
    Durbecq V; Desmed C; Paesmans M; Cardoso F; Di Leo A; Mano M; Rouas G; Leroy JY; Sotiriou C; Piccart M; Larsimont D
    Int J Oncol; 2004 Nov; 25(5):1473-9. PubMed ID: 15492841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes.
    Olsen KE; Knudsen H; Rasmussen BB; Balslev E; Knoop A; Ejlertsen B; Nielsen KV; Schönau A; Overgaard J;
    Acta Oncol; 2004; 43(1):35-42. PubMed ID: 15068318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expressions of HER2 and Topo IIα in breast cancer and 
its clinical significance].
    Shuai P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1143-1147. PubMed ID: 27932758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?
    Di Leo A; Isola J
    Clin Breast Cancer; 2003 Aug; 4(3):179-86. PubMed ID: 14499010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of HER2 gene amplification by fluorescence in situ hybridization in breast cancer.
    Bartlett JM; Forsyth A
    Methods Mol Med; 2006; 120():309-22. PubMed ID: 16491609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topoisomerase II-alpha (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy.
    Park K; Kim J; Lim S; Han S
    Eur J Cancer; 2003 Mar; 39(5):631-4. PubMed ID: 12628842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.
    Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y
    J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing two diagnostic laboratory tests for Williams syndrome: fluorescent in situ hybridization versus multiplex ligation-dependent probe amplification.
    van Hagen JM; Eussen HJ; van Schooten R; van Der Geest JN; Lagers-van Haselen GC; Wouters CH; De Zeeuw CI; Gille JJ
    Genet Test; 2007; 11(3):321-7. PubMed ID: 17949295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased lymphocytic infiltration in breast cancer correlated with molecular subtypes and HER2 gene amplification.
    Tsang JY; Ni YB; Chan SK; Yamaguchi R; Tanaka M; Tan PH; Tse GM
    Histopathology; 2013 May; 62(6):963-5. PubMed ID: 23551496
    [No Abstract]   [Full Text] [Related]  

  • 60. Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Ooi A; Inokuchi M; Horike SI; Kawashima H; Ishikawa S; Ikeda H; Nakamura R; Oyama T; Dobashi Y
    Hum Pathol; 2019 Mar; 85():33-43. PubMed ID: 30385370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.